Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04004364 · ClinicalTrials.gov registry record

Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes

A clinical trial of First Episode Psychosis, sponsored by Northwell Health.

Recruiting
Registry status
700
Enrollment target
1
Study location

NCT04004364 is a study of First Episode Psychosis that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 700 participants, below the 6,345-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04004364, a study of First Episode Psychosis, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
700 participants
Enrollment target
1
Study location

Study Summary

The goal if the project is to develop a learning health network devoted to the treatment of first episode psychosis.

Conditions Studied

Interventions

  • OTHER Coordinated Specialty Care (CSC)

Study Locations (1)

Florida

  • Henderson Behavioral Health - Lauderdale Lakes

Trial Details

FieldValue
Enrollment Target 700 participants
Start Date 2020-04-01
Est. Completion 2025-03-31

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT04004364

The ClinicalTrials.gov registry entry for NCT04004364 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,345-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (89% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with First Episode Psychosis appearing as the primary indexed condition, and to 1 intervention - of which Coordinated Specialty Care (CSC) is the first listed.

NCT04004364 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04004364 about?

NCT04004364 is a clinical study titled "Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes". The goal if the project is to develop a learning health network devoted to the treatment of first episode psychosis.

What is the current status of trial NCT04004364?

This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2020-04-01. Estimated completion is 2025-03-31.

What conditions does trial NCT04004364 study?

This clinical trial studies the following conditions: First Episode Psychosis.

What interventions are being tested in trial NCT04004364?

The interventions under investigation include: Coordinated Specialty Care (CSC) (OTHER).

Who is sponsoring clinical trial NCT04004364?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04004364 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for First Episode Psychosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.